Optical Coherence Tomography Angiography (OCT-A) and Central Serous Chorioretinopathy (CSC)

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Central Serous Chorioretinopathy
Interventions
DEVICE

Optical Coherence Tomography Angiography (OCT-A)

Optical Coherence Tomography Angiography (OCT-A) images were acquired using an Spectral Domain Optical Coherence Tomography device (Cirrus High Definition OCT Model 5000 with Angioplex; Carl Zeiss Meditec, Dublin, California, USA). With an acquisition speed of 68,000 A-Scan per second, the OCT Microangiography Complex algorithm provided OCT-A information for three-dimensional (3D) flow reconstruction. At each visit, each subject underwent a 3 x 3 millimeter (mm) macular 3D cube acquisition in both eyes. FastTrac continuous eye tracking technology was employed to control for eye movements and minimize motion artefacts.

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03950089 - Optical Coherence Tomography Angiography (OCT-A) and Central Serous Chorioretinopathy (CSC) | Biotech Hunter | Biotech Hunter